Loading cancer entity…
Loading cancer entity…
Clinical trials
5 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02834013 | Nivolumab and Ipilimumab in Treating Patients With Rare Tumors | active not recruiting | Phase 2 | 798 | National Cancer Institute (NCI)NIH | 2 | Jun 17, 2026 | clinicaltrials |
| NCT01793168 | Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford(CoRDS) | recruiting | — | 20,000 | Sanford HealthOTHER | 2 | May 29, 2025 | clinicaltrials |
| NCT05964101 | Nivolumab Combined With Chemotherapy in the Treatment of Primary Tracheal Squamous Cell Carcinoma(GALAXY-1) | unknown | Phase 2 | 25 | The First Affiliated Hospital of Guangzhou Medical UniversityOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT04716751 | Toripalimab Combined With Chemotherapy in Primary Tracheal Squamous Cell Carcinoma | unknown | Phase 2 |
Data updated 22 days agoSource updated Jun 17, 2026source: clinicaltrials
| 15 |
| Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER |
| 0 |
| Jan 26, 2021 |
| clinicaltrials |
| NCT01331863 | Airway and/or Pulmonary Vessels Transplantation(TRACHBRONCAR) | completed | Phase 1 / Phase 2 | 16 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Sep 9, 2020 | clinicaltrials |